Publication: Chitosan-alginate nanoparticles as effective oral carriers to improve the stability, bioavailability, and cytotoxicity of curcumin diethyl disuccinate
3
Issued Date
2020-01-01
Resource Type
ISSN
01448617
Other identifier(s)
2-s2.0-85097399406
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Carbohydrate Polymers. (2020)
Suggested Citation
Feuangthit Niyamissara Sorasitthiyanukarn, Chawanphat Muangnoi, Pornchai Rojsitthisak, Pranee Rojsitthisak Chitosan-alginate nanoparticles as effective oral carriers to improve the stability, bioavailability, and cytotoxicity of curcumin diethyl disuccinate. Carbohydrate Polymers. (2020). doi:10.1016/j.carbpol.2020.117426 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/60436
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Chitosan-alginate nanoparticles as effective oral carriers to improve the stability, bioavailability, and cytotoxicity of curcumin diethyl disuccinate
Other Contributor(s)
Abstract
© 2020 Elsevier Ltd Curcumin diethyl disuccinate (CDD) is an ester prodrug of curcumin that has better chemical stability in phosphate buffer (pH 7.4) and anticancer activities against MDA-MB-231 human breast cancer cells and Caco-2 cells than curcumin. However, a major drawback of CDD is its poor water solubility and low bioavailability in the gastrointestinal tract. To overcome these problems, a nanoformulation was developed using chitosan/alginate nanoparticles (CANPs) under the optimal condition as previously derived by statistical optimization. The CDD-loaded CANPs (CDD-CANPs) were found to exhibit good stability after exposure to simulated digestive fluids and ultraviolet light, and a sustained-release profile of CDD in the simulated digestive and body fluids. The in vitro release pattern fitted well to the Peppas-Sahlin model, indicating that the release of CDD was mainly governed by diffusion. Compared to free CDD, the CDD-CANPs showed better stability, bioaccessibility, bioavailability, cellular uptake, and cytotoxicity against HepG2 cells.
